Somatostatin Receptors Icso 0.09 To 0.2nm Websites
Andarix Pharmaceuticals, Inc.
- andarix.info
Andarix Pharmaceuticals is a clinical stage company developing a targeted personalized treatment for lung, breast and other cancers based on a proprietary somatostatin peptide conjugate (P2045). Extensive research has demonstrated that Somatostatin receptors are highly up-regulated on several solid tumors, particularly
Not Applicable
$
8.95